BIOPLASTY LICENSES SYNTHETIC WOUND CARE DRESSING
BIOPLASTY LICENSES SYNTHETIC WOUND CARE DRESSING ST. PAUL, Minn., Jan. 15 /PRNewswire/ -- Bioplasty, Inc.
(NASDAQ: BIOP), a Minnesota-based manufacturer and marketer of plastic surgery and urology products announced today that it has entered into a license agreement with Enquay Pharmaceutical Associates for its DIMAC(TM) and SILDIMAC(TM) synthetic wound care products.
DIMAC is a polymer matrix system which can store many types and classes of drugs and chemical agents and releases the embodied material in a desirable steady-state rate so that the optimal clinical response is achieved. DIMAC serves as the storage and delivery system for the drug silver sulfadiazine to be used in the treatment of burns in burn centers and outpatient emergency rooms and has been given the trade name SILDIMAC Delivery System(TM). United States Patent number 4,563,184 covering these products and a New Drug Application (NDA) approval for marketing of SILDIMAC has been granted by the Food and Drug Administration. Bioplasty expects to begin manufacturing SILDIMAC in its new facility scheduled for completion sometime in mid-1992. SILDIMAC is expected to complement Bioplasty's existing wound care product line including MEDISKIN(R) Porcine Biological and E-Z DERM(TM) biosynthetic wound dressings. Bioplasty, Inc. has more than 20 years of experience in the development, manufacturing and marketing of plastic surgery products worldwide. Bioplasty's stock is currently traded on NASDAQ National Market System under the symbol BIOP. -0- 1/15/92 /CONTACT: Timothy P. Lawin or Donald A. Major of Bioplasty, 612-636-4112, or Dr. Bernard Korol or Dr. Paul Nathan of Enquay Pharmaceutical Associates, 407-338-7041/ (BIOP) CO: Bioplasty, Inc., Enquay Pharmaceutical Associates ST: Minnesota IN: MTC SU: LIC
KH -- MN009 -- 0062 01/15/92 14:02 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 15, 1992|
|Previous Article:||EVANS TO HEAD DORNA, USA; APPOINTS BURNETTE AS EXECUTIVE VICE PRESIDENT|
|Next Article:||MEI DIVERSIFIED SUBSIDIARY TO LAUNCH NEW PRODUCT LINE (Product Announcement)|